Cosmo,
Our JV at Egina is 30% with Novo and 40% with Sumitomo, with Novo bearing all PIO costs till a "decision to mine". While I don't disagree that Novo is an excellent partner, the partnership with Sumitomo is much more important. I don't believe that Sumitomo has ever before been in a JV with junior explorers, certainly not one as junior as PIO. They smell something huge!
- Forums
- ASX - By Stock
- ESS
- 2020..year of Pioneer
2020..year of Pioneer, page-20
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ESS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online